Protocol Index	

If this file opens in Compatibility Mode using Microsoft Word, convert to the latest document format to avoid potential formatting issues.	

OP RSH PRO00036343 / IMCGP100-203 / ARM C	

Types:      Research Oncology Treatment
Synonyms:  PRO00036343, ARM C, CGP100

Week 1	Repeat 1 time	Cycle length: 7 days	Day 1	Perform every 1 day x1		Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Plasma for ctDNA. Plasma samples for ctDNA are to be collected pre-dose (within 2 hr) on dosing days and Q6W from Week 9. The sample window is ± 2 weeks from all designated time points after Week 9. Participants should be asked to come to the clinic for the Week 9 ctDNA sample collection even in the event of early discontinuation from the study
				Day 2	Perform every 1 day x1		Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Plasma for ctDNA. Plasma samples for ctDNA are to be collected pre-dose (within 2 hr) on dosing days and Q6W from Week 9. The sample window is ± 2 weeks from all designated time points after Week 9. Participants should be asked to come to the clinic for the Week 9 ctDNA sample collection even in the event of early discontinuation from the study
					
Week 9	Repeat 1 time	Cycle length: 7 days	Day 1	Perform every 1 day x1		Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Plasma for ctDNA. Plasma samples for ctDNA are to be collected pre-dose (within 2 hr) on dosing days and Q6W from Week 9. The sample window is ± 2 weeks from all designated time points after Week 9. Participants should be asked to come to the clinic for the Week 9 ctDNA sample collection even in the event of early discontinuation from the study
					
Survival FU for 2 years	Repeat 1 time	Cycle length: 1 day	Day 1	Perform every 0 days x1		Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	Subsequent anticancer therapy.
		  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	Survival contact.